journal article·2008-06-11

Quantum dot-labeled aptamer nanoprobes specifically targeting glioma cells

Xue-Chai Chen, Yu-Lin Deng, Yi Lin, Dai-Wen Pang, Hong Qing, Feng Qu, Hai-Yan Xie

Nanotechnology· Volume 19· Issue 23
Publisher page

Abstract

Two new techniques, aptamer-based specific recognition and quantum dot (QD)-based fluorescence labeling, are becoming increasingly important in biosensing. In this study, these two techniques have been coupled together to construct a new kind of fluorescent QD-labeled aptamer (QD-Apt) nanoprobe by conjugating GBI-10 aptamer to the QD surface. GBI-10 is a single-stranded DNA (ssDNA) aptamer for tenascin-C, which distributes on the surface of glioma cells as a dominant extracellular matrix protein. The QD-Apt nanoprobe can recognize the tenascin-C on the human glioma cell surface, which will be helpful for the development of new convenient and sensitive in vitro diagnostic assays for glioma. The QD-Apt nanoprobe has particular features such as strong fluorescence, stability, monodispersity and uniformity. In addition, this probe preparation method is universal, so it is expected to provide a new type of stable nanoprobe for high-throughput and fast biosensing detection and bioimaging. New methods for real-time and dynamic tracking and imaging can be accordingly developed.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Biosensors and Analytical Detection · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (21)

Show source-provided references
1. 10.1126/science.110427410.1126/science.1104274 ↗
2. 10.1146/annurev.bioeng.7.060804.10043210.1146/annurev.bioeng.7.060804.100432 ↗
3. 10.1038/nprot.2007.10710.1038/nprot.2007.107 ↗
4. Bunka D H J · Nature · 2006 · 4 · 588
5. Mukhopadhyay R · Anal. Chem. · 2005 · 77 · 115A-8A
6. 10.1023/A:102669633024510.1023/A:1026696330245 ↗
7. 10.1007/s10895-007-0158-410.1007/s10895-007-0158-4 ↗
8. 10.1021/ja066506k10.1021/ja066506k ↗
9. 10.1117/12.59724910.1117/12.597249 ↗
10. 10.1016/j.bios.2005.12.01510.1016/j.bios.2005.12.015 ↗
11. 10.1021/nl071546n10.1021/nl071546n ↗
12. Cottingham K · Anal. Chem. · 2005 · 77 · 354A-7A10.1021/ac050212k ↗
13. 10.1073/pnas.213668310010.1073/pnas.2136683100 ↗
14. 10.1002/glia.44015030610.1002/glia.440150306 ↗
15. 10.1002/(SICI)1097-0215(19990812)82:4<477::AID-IJC2>3.0.CO;2-510.1002/(SICI)1097-0215(19990812)82:4<477::AID-IJC2>3.0.CO;2-5 ↗
16. Riva P · Clin. Cancer Res. · 1999 · 5 · 3275s-80s
17. 10.1166/jnn.2005.11910.1166/jnn.2005.119 ↗
18. 10.1126/science.107719410.1126/science.1077194 ↗
19. 10.1002/cphc.20050060810.1002/cphc.200500608 ↗
20. 10.1126/science.287.5454.82010.1126/science.287.5454.820 ↗
21. 10.1016/j.bioeng.2007.06.00310.1016/j.bioeng.2007.06.003 ↗